Updated:
Denali Ventures
Denali Ventures is an Israeli-based venture capital firm investing in life science and health care technology companies. The firm has made 9 investments,...
Denali Ventures
Denali Ventures is an Israeli-based venture capital firm investing in life science and health care technology companies. The firm has made 9 investments, including a Series E investment in Gamida Cell on May 15, 2012. Denali Ventures has 2 portfolio exits, with Gamida Cell being its latest exit on October 26, 2018.
General information
Firm type
Venture Capital
Year founded
2001
Location
Region
North America
Country
United States
City
Menlo Park
Corporate office
Menlo Park, CA, United States
Additional offices
Charlotte, NC · Herzliya, Israel
Sector focus
Frequently asked questions
Where does Denali Ventures source deals?
Denali Ventures sources deals primarily through its networks in the Israeli technology ecosystem and US enterprise corridors. With offices in Herzliya, Menlo Park, and Charlotte, the firm has access to the deep technology talent pool in Israel and the commercial customer base and later-stage capital networks in the United States, per its official communications.
What is the significance of the firm's office in Charlotte, North Carolina?
The Charlotte office positions Denali Ventures within a growing financial services and enterprise technology hub in the Southeast. This location provides portfolio companies with alternative paths to corporate customers, partnerships, and talent outside the traditional coastal tech centers, complementing the firm's Menlo Park presence.
How is Denali Ventures structured to support portfolio companies?
Rather than operating as a purely financial investment vehicle, Denali Ventures maintains a distributed team across three offices to offer operational and go-to-market support. For Israeli companies entering the US market, the firm's physical presence in California and North Carolina provides logistical and network advantages during critical scaling phases.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: